Guido Ahle

2.4k total citations
42 papers, 577 citations indexed

About

Guido Ahle is a scholar working on Neurology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Guido Ahle has authored 42 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Neurology, 22 papers in Genetics and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Guido Ahle's work include CNS Lymphoma Diagnosis and Treatment (20 papers), Glioma Diagnosis and Treatment (20 papers) and Lymphoma Diagnosis and Treatment (15 papers). Guido Ahle is often cited by papers focused on CNS Lymphoma Diagnosis and Treatment (20 papers), Glioma Diagnosis and Treatment (20 papers) and Lymphoma Diagnosis and Treatment (15 papers). Guido Ahle collaborates with scholars based in France, Germany and Switzerland. Guido Ahle's co-authors include Caroline Houillier, Carole Soussain, Khê Hoang‐Xuan, Markus M. Nöthen, Thomas G. Schulze, Marcella Rietschel, Magali Le Garff‐Tavernier, Alexander Baraniskin, Uwe Schlegel and D Müller and has published in prestigious journals such as Blood, Neurology and Annals of Neurology.

In The Last Decade

Guido Ahle

36 papers receiving 569 citations

Peers

Countries citing papers authored by Guido Ahle

Since Specialization

Citations

This map shows the geographic impact of Guido Ahle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Ahle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Ahle more than expected).

Fields of papers citing papers by Guido Ahle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Ahle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Ahle. The network helps show where Guido Ahle may publish in the future.

Co-authorship network of co-authors of Guido Ahle

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Ahle. A scholar is included among the top collaborators of Guido Ahle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Ahle. Guido Ahle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Early use of high efficacy therapies in pediatric forms of relapsing-remitting multiple sclerosis: A real-life observational study 2023 ·Multiple Sclerosis and Related Disorders ·(unknown), (unknown), Laurent Kremer, Marie Fleury, (unknown), François Sellal, (unknown), Guido Ahle, Sylvie Courtois, (unknown), (unknown), (unknown), Nicolas Collongues, J. de Sèze, Kévin Bigaut	7
2	Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study 2023 ·Annals of Hematology ·Jean‐François Dufour, Sylvain Choquet, Khê Hoang‐Xuan, Anna Schmitt, Guido Ahle, Roch Houot, Luc Taillandier, Rémy Gressin, Olivier Casasnovas, JP Marolleau, Jérôme Tamburini, (unknown), (unknown), Jérôme Paillassa, Emmanuel Gyan, Adrien Chauchet, Rénata Ursu, Aurélie Kas, Carole Soussain, Caroline Houillier	2
3	Ocrelizumab versus fingolimod after natalizumab cessation in multiple sclerosis: an observational study 2022 ·Journal of Neurology ·Kévin Bigaut, Laurent Kremer, Thibaut Fabacher, Guido Ahle, Mathilde Goudot, Marie Fleury, (unknown), Sylvie Courtois, Nicolas Collongues, J. de Sèze	12
4	CSF biomarkers in primary CNS lymphoma 2022 ·Revue Neurologique ·(unknown), Agustí Alentorn, Guido Ahle, Carole Soussain, Bertrand Mathon, (unknown), Caroline Houillier, Khê Hoang‐Xuan	9
5	Troubles du système nerveux central sous lorlatinib : comment les détecter et les gérer en pratique ? 2022 ·Bulletin du Cancer ·Vincent Fallet, (unknown), Guido Ahle, Jennifer Arrondeau, Charles Naltet, (unknown), (unknown), H. Léna, Alexis B. Cortot	0
6	CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma 2021 ·Journal of Neurology ·Aurelian Ungureanu, Magali Le Garff‐Tavernier, Myrto Costopoulos, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), François Sellal, Guido Ahle	12
7	Late-onset riboflavin transporter deficiency: a treatable mimic of various motor neuropathy aetiologies 2020 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Charline Benoit, Guido Ahle, Cécile Cauquil, Agathe Roubertie, Timothée Lenglet, Jeremy Cosgrove, Isabelle Meunier, (unknown), Cécile Acquaviva, Yann Nadjar	15
8	1673MO The GCO-002 CACOVID-19 cohort: A French nationwide multicenter study of COVID-19 infected cancer patients and consequences on cancer management 2020 ·Annals of Oncology ·Astrid Lièvre, Anthony Turpin, Isabelle Laure Ray-Coquard, Karine Le Malicot, Juliette Thariat, Guido Ahle, Romain Mathiéu, (unknown), D. Debieuvre, Anthony Canellas, (unknown), Raphaël Colle, (unknown), Luigi Mansi, Jean Bourhis, Philippe Gorphe, Rénata Ursu, (unknown), Gérard Zalcman, Olivier Bouché	1
9	Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study 2019 ·Journal of Neuro-Oncology ·(unknown), Nelly Étienne-Selloum, (unknown), Marie Blonski, Luc Taillandier, Véronique Lorgis, G. Noël, Guido Ahle, Alberto Durán-Peña, Mathieu Boone, Bruno Chauffert	9
10	Complementary and alternative medicine use in glioma patients in France 2019 ·Journal of Neuro-Oncology ·Émilie Le Rhun, Patrick Devos, Véronique Bourg, Amélie Darlix, Véronique Lorgis, Guido Ahle, Mathieu Boone, Luc Taillandier, Elsa Curtit, L. Gras, Christine Lebrun‐Frénay, Dorothee Gramatzki, Carole Ramirez, Nicolas Simon, Michael Weller	6
11	Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder 2018 ·Revue Neurologique ·Aurelian Ungureanu, J. de Sèze, Guido Ahle, François Sellal	7
12	MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS 2018 ·Journal of Neuro-Oncology ·Alexander Baraniskin, (unknown), Guido Ahle, Thomas M. Gress, Malte Buchholz, Michael Turewicz, Martin Eisenacher, (unknown), Uwe Schlegel, Wolff Schmiegel, Stephan A. Hahn, Roland Schroers	25
13	Optic nerve sheath meningioma detected by single- photon emission computed tomography/computed tomography somatostatin receptor scintigraphy: a case report 2016 ·Journal of Medical Case Reports ·(unknown), Guido Ahle, (unknown), (unknown), Izzie Jacques Namer	4
14	Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse 2016 ·Cancer/Radiothérapie ·D. Antoni, (unknown), (unknown), (unknown), Guido Ahle, (unknown), (unknown), Roland Schött, (unknown), (unknown), (unknown), G. Noël	15
15	The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients 2016 ·European Journal of Cancer ·(unknown), Myrto Costopoulos, Marie‐Laure Tanguy, Caroline Houillier, Sylvain Choquet, (unknown), (unknown), Marine Armand, Géraldine Faivre, Sylvie Glaisner, Sandra Malak, Jacques Vargaftig, Khê Hoang‐Xuan, Guido Ahle, Valérie Touitou, Nathalie Cassoux, Frédéric Davi, Hélène Merle‐Béral, Magali Le Garff‐Tavernier, Carole Soussain	68
16	Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma 2015 ·Neuro-Oncology ·Alexander Baraniskin, (unknown), (unknown), Guido Ahle, Sabine Seidel, Uwe Schlegel, Wolff Schmiegel, Stephan A. Hahn, Roland Schroers	41
17	SMART Syndrome : à propos d’un cas d’une complication rare après radiothérapie cérébrale et revue de la littérature 2012 ·Cancer/Radiothérapie ·(unknown), A. Monjour, (unknown), Guido Ahle, (unknown), (unknown), (unknown), Paul Salze, (unknown)	2
18	Shape changes in prefrontal, but not parieto-occipital regions: brains of schizophrenic patients come closer to a circle in coronal and sagittal view 2004 ·Psychiatry Research Neuroimaging ·Peter Falkai, Ralf Tepest, William G. Honer, (unknown), Guido Ahle, U. Pfeiffer, Kai Vogeley, Thomas G. Schulze, Marcella Rietschel, Joachim Cordes, (unknown), Wolfgang Gäebel, (unknown), Wolfgang Maier, Frank Träber, Wolfgang Block, Hans H. Schild, Neil Thomas	6
19	Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia 2001 ·American Journal of Medical Genetics ·Thomas G. Schulze, Johannes Schumacher, Daniel J. Müller, Harald Krauß, (unknown), (unknown), Guido Ahle, (unknown), (unknown), (unknown), Tilo Held, Peter Propping, Wolfgang Maier, Markus M. Nöthen, Marcella Rietschel	53
20	Familial occurrence of tardive dyskinesia 2001 ·Acta Psychiatrica Scandinavica ·D Müller, Thomas G. Schulze, Martín Knapp, T. Held, (unknown), (unknown), Guido Ahle, (unknown), (unknown), Wolfgang Maier, Markus M. Nöthen, Marcella Rietschel	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact